Drug firm Nectar Lifesciences reported a sales turnover of Rs 341.36 crore and a net profit of Rs 31.83 crore for the quarter ended March '11. Dinesh Dua, CEO, Nectar Lifesciences in an interview with CNBC-TV18 spoke about the latest happenings in the company and the road ahead.
He said, "We expect close to about Rs 250-300 crore coming out of the regulated markets in the year '13-'14Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
